Global Liposomes Drug Delivery Sales Market Report 2021

Global Liposomes Drug Delivery Sales Market Report 2021

Table of Contents
1 Liposomes Drug Delivery Market Overview
1.1 Liposomes Drug Delivery Product Scope
1.2 Liposomes Drug Delivery Segment by Type
1.2.1 Global Liposomes Drug Delivery Sales by Type (2016 & 2021 & 2027)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposomes Drug Delivery Segment by Application
1.3.1 Global Liposomes Drug Delivery Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Liposomes Drug Delivery Market Estimates and Forecasts (2016-2027)
1.4.1 Global Liposomes Drug Delivery Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Liposomes Drug Delivery Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Liposomes Drug Delivery Price Trends (2016-2027)
2 Liposomes Drug Delivery Estimates and Forecasts by Region
2.1 Global Liposomes Drug Delivery Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Liposomes Drug Delivery Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Liposomes Drug Delivery Sales Market Share by Region (2016-2021)
2.2.2 Global Liposomes Drug Delivery Revenue Market Share by Region (2016-2021)
2.3 Global Liposomes Drug Delivery Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Liposomes Drug Delivery Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Liposomes Drug Delivery Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.2 Europe Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.3 China Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.4 Japan Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.6 India Liposomes Drug Delivery Estimates and Projections (2016-2027)
3 Global Liposomes Drug Delivery Competition Landscape by Players
3.1 Global Top Liposomes Drug Delivery Players by Sales (2016-2021)
3.2 Global Top Liposomes Drug Delivery Players by Revenue (2016-2021)
3.3 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomes Drug Delivery as of 2020)
3.4 Global Liposomes Drug Delivery Average Price by Company (2016-2021)
3.5 Manufacturers Liposomes Drug Delivery Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Liposomes Drug Delivery Market Size by Type
4.1 Global Liposomes Drug Delivery Historic Market Review by Type (2016-2021)
4.1.1 Global Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
4.1.2 Global Liposomes Drug Delivery Revenue Market Share by Type (2016-2021)
4.1.3 Global Liposomes Drug Delivery Price by Type (2016-2021)
4.2 Global Liposomes Drug Delivery Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Liposomes Drug Delivery Sales Forecast by Type (2022-2027)
4.2.2 Global Liposomes Drug Delivery Revenue Forecast by Type (2022-2027)
4.2.3 Global Liposomes Drug Delivery Price Forecast by Type (2022-2027)
5 Global Liposomes Drug Delivery Market Size by Application
5.1 Global Liposomes Drug Delivery Historic Market Review by Application (2016-2021)
5.1.1 Global Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
5.1.2 Global Liposomes Drug Delivery Revenue Market Share by Application (2016-2021)
5.1.3 Global Liposomes Drug Delivery Price by Application (2016-2021)
5.2 Global Liposomes Drug Delivery Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Liposomes Drug Delivery Sales Forecast by Application (2022-2027)
5.2.2 Global Liposomes Drug Delivery Revenue Forecast by Application (2022-2027)
5.2.3 Global Liposomes Drug Delivery Price Forecast by Application (2022-2027)
6 North America Liposomes Drug Delivery Market Facts & Figures
6.1 North America Liposomes Drug Delivery Sales by Company
6.1.1 North America Liposomes Drug Delivery Sales by Company (2016-2021)
6.1.2 North America Liposomes Drug Delivery Revenue by Company (2016-2021)
6.2 North America Liposomes Drug Delivery Sales Breakdown by Type
6.2.1 North America Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
6.2.2 North America Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
6.3 North America Liposomes Drug Delivery Sales Breakdown by Application
6.3.1 North America Liposomes Drug Delivery Sales Breakdown by Application (2016-2021)
6.3.2 North America Liposomes Drug Delivery Sales Breakdown by Application (2022-2027)
7 Europe Liposomes Drug Delivery Market Facts & Figures
7.1 Europe Liposomes Drug Delivery Sales by Company
7.1.1 Europe Liposomes Drug Delivery Sales by Company (2016-2021)
7.1.2 Europe Liposomes Drug Delivery Revenue by Company (2016-2021)
7.2 Europe Liposomes Drug Delivery Sales Breakdown by Type
7.2.1 Europe Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
7.2.2 Europe Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
7.3 Europe Liposomes Drug Delivery Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Liposomes Drug Delivery Market Facts & Figures
8.1 China Liposomes Drug Delivery Sales by Company
8.1.1 China Liposomes Drug Delivery Sales by Company (2016-2021)
8.1.2 China Liposomes Drug Delivery Revenue by Company (2016-2021)
8.2 China Liposomes Drug Delivery Sales Breakdown by Type
8.2.1 China Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
8.2.2 China Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
8.3 China Liposomes Drug Delivery Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Liposomes Drug Delivery Market Facts & Figures
9.1 Japan Liposomes Drug Delivery Sales by Company
9.1.1 Japan Liposomes Drug Delivery Sales by Company (2016-2021)
9.1.2 Japan Liposomes Drug Delivery Revenue by Company (2016-2021)
9.2 Japan Liposomes Drug Delivery Sales Breakdown by Type
9.2.1 Japan Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
9.2.2 Japan Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
9.3 Japan Liposomes Drug Delivery Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Liposomes Drug Delivery Market Facts & Figures
10.1 Southeast Asia Liposomes Drug Delivery Sales by Company
10.1.1 Southeast Asia Liposomes Drug Delivery Sales by Company (2016-2021)
10.1.2 Southeast Asia Liposomes Drug Delivery Revenue by Company (2016-2021)
10.2 Southeast Asia Liposomes Drug Delivery Sales Breakdown by Type
10.2.1 Southeast Asia Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Liposomes Drug Delivery Sales Breakdown by Application
10.3.1 Southeast Asia K Vial Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Vial Sales Breakdown by Application (2022-2027)
11 India Liposomes Drug Delivery Market Facts & Figures
11.1 India Liposomes Drug Delivery Sales by Company
11.1.1 India Liposomes Drug Delivery Sales by Company (2016-2021)
11.1.2 India Liposomes Drug Delivery Revenue by Company (2016-2021)
11.2 India Liposomes Drug Delivery Sales Breakdown by Type
11.2.1 India Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
11.2.2 India Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
11.3 India Liposomes Drug Delivery Sales Breakdown by Application
11.3.1 India Liposomes Drug Delivery Sales Breakdown by Application (2016-2021)
11.3.2 India Liposomes Drug Delivery Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Liposomes Drug Delivery Business
12.1 Gilead Sciences
12.1.1 Gilead Sciences Corporation Information
12.1.2 Gilead Sciences Business Overview
12.1.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Sciences Liposomes Drug Delivery Products Offered
12.1.5 Gilead Sciences Recent Development
12.2 Pacira
12.2.1 Pacira Corporation Information
12.2.2 Pacira Business Overview
12.2.3 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pacira Liposomes Drug Delivery Products Offered
12.2.5 Pacira Recent Development
12.3 Sun Pharmaceutical
12.3.1 Sun Pharmaceutical Corporation Information
12.3.2 Sun Pharmaceutical Business Overview
12.3.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sun Pharmaceutical Liposomes Drug Delivery Products Offered
12.3.5 Sun Pharmaceutical Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Business Overview
12.4.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Liposomes Drug Delivery Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Corporation Information
12.5.2 Luye Pharma Business Overview
12.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Luye Pharma Liposomes Drug Delivery Products Offered
12.5.5 Luye Pharma Recent Development
12.6 Sigma-Tau Group
12.6.1 Sigma-Tau Group Corporation Information
12.6.2 Sigma-Tau Group Business Overview
12.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sigma-Tau Group Liposomes Drug Delivery Products Offered
12.6.5 Sigma-Tau Group Recent Development
12.7 Ipsen (Onivyde)
12.7.1 Ipsen (Onivyde) Corporation Information
12.7.2 Ipsen (Onivyde) Business Overview
12.7.3 Ipsen (Onivyde) Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ipsen (Onivyde) Liposomes Drug Delivery Products Offered
12.7.5 Ipsen (Onivyde) Recent Development
12.8 CSPC
12.8.1 CSPC Corporation Information
12.8.2 CSPC Business Overview
12.8.3 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CSPC Liposomes Drug Delivery Products Offered
12.8.5 CSPC Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Corporation Information
12.9.2 Teva Pharmaceutical Business Overview
12.9.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Teva Pharmaceutical Liposomes Drug Delivery Products Offered
12.9.5 Teva Pharmaceutical Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Business Overview
12.10.3 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis Liposomes Drug Delivery Products Offered
12.10.5 Novartis Recent Development
12.11 Fudan-Zhangjiang
12.11.1 Fudan-Zhangjiang Corporation Information
12.11.2 Fudan-Zhangjiang Business Overview
12.11.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Fudan-Zhangjiang Liposomes Drug Delivery Products Offered
12.11.5 Fudan-Zhangjiang Recent Development
13 Liposomes Drug Delivery Manufacturing Cost Analysis
13.1 Liposomes Drug Delivery Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Liposomes Drug Delivery
13.4 Liposomes Drug Delivery Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Liposomes Drug Delivery Distributors List
14.3 Liposomes Drug Delivery Customers
15 Market Dynamics
15.1 Liposomes Drug Delivery Market Trends
15.2 Liposomes Drug Delivery Drivers
15.3 Liposomes Drug Delivery Market Challenges
15.4 Liposomes Drug Delivery Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Liposomes Drug Delivery Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Liposomes Drug Delivery Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Liposomes Drug Delivery Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Liposomes Drug Delivery Sales (K Vial) by Region (2016-2021)
Table 5. Global Liposomes Drug Delivery Sales Market Share by Region (2016-2021)
Table 6. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Liposomes Drug Delivery Revenue Share by Region (2016-2021)
Table 8. Global Liposomes Drug Delivery Sales (K Vial) Forecast by Region (2022-2027)
Table 9. Global Liposomes Drug Delivery Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Liposomes Drug Delivery Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Liposomes Drug Delivery Revenue Share Forecast by Region (2022-2027)
Table 12. Global Liposomes Drug Delivery Sales (K Vial) of Key Companies (2016-2021)
Table 13. Global Liposomes Drug Delivery Sales Share by Company (2016-2021)
Table 14. Global Liposomes Drug Delivery Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Liposomes Drug Delivery Revenue Share by Company (2016-2021)
Table 16. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomes Drug Delivery as of 2020)
Table 17. Global Liposomes Drug Delivery Average Price (USD/Vial) of Key Company (2016-2021)
Table 18. Manufacturers Liposomes Drug Delivery Manufacturing Sites and Area Served
Table 19. Manufacturers Liposomes Drug Delivery Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Liposomes Drug Delivery Sales (K Vial) by Type (2016-2021)
Table 22. Global Liposomes Drug Delivery Sales Share by Type (2016-2021)
Table 23. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2016-2021)
Table 25. Global Liposomes Drug Delivery Sales Share by Type (2022-2027)
Table 26. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Liposomes Drug Delivery Revenue Share by Type (2022-2027)
Table 28. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2022-2027)
Table 29. Global Liposomes Drug Delivery Sales (K Vial) by Application (2016-2021)
Table 30. Global Liposomes Drug Delivery Sales Share by Application (2016-2021)
Table 31. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2016-2021)
Table 33. Global Liposomes Drug Delivery Sales (K Vial) by Application (2022-2027)
Table 34. Global Liposomes Drug Delivery Sales Share by Application (2022-2027)
Table 35. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Liposomes Drug Delivery Revenue Share by Application (2022-2027)
Table 37. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2022-2027)
Table 38. North America Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 39. North America Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 40. North America Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 42. North America Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 43. North America Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 44. North America Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 45. North America Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 46. North America Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 47. North America Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 48. North America Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 49. North America Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 50. Europe Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 51. Europe Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 52. Europe Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 54. Europe Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 55. Europe Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 56. Europe Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 57. Europe Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 58. Europe Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 59. Europe Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 60. Europe Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 61. Europe Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 62. China Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 63. China Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 64. China Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 66. China Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 67. China Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 68. China Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 69. China Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 70. China Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 71. China Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 72. China Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 73. China Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 74. Japan Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 75. Japan Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 76. Japan Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 78. Japan Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 79. Japan Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 80. Japan Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 81. Japan Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 82. Japan Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 83. Japan Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 84. Japan Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 85. Japan Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 87. Southeast Asia Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 91. Southeast Asia Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 93. Southeast Asia Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 95. Southeast Asia Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 97. Southeast Asia Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 98. India Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 99. India Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 100. India Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 102. India Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 103. India Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 104. India Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 105. India Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 106. India Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 107. India Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 108. India Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 109. India Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 110. Gilead Sciences Corporation Information
Table 111. Gilead Sciences Description and Business Overview
Table 112. Gilead Sciences Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 113. Gilead Sciences Liposomes Drug Delivery Product
Table 114. Gilead Sciences Recent Development
Table 115. Pacira Corporation Information
Table 116. Pacira Description and Business Overview
Table 117. Pacira Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 118. Pacira Liposomes Drug Delivery Product
Table 119. Pacira Recent Development
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 123. Sun Pharmaceutical Liposomes Drug Delivery Product
Table 124. Sun Pharmaceutical Recent Development
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 128. Johnson & Johnson Liposomes Drug Delivery Product
Table 129. Johnson & Johnson Recent Development
Table 130. Luye Pharma Corporation Information
Table 131. Luye Pharma Description and Business Overview
Table 132. Luye Pharma Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 133. Luye Pharma Liposomes Drug Delivery Product
Table 134. Luye Pharma Recent Development
Table 135. Sigma-Tau Group Corporation Information
Table 136. Sigma-Tau Group Description and Business Overview
Table 137. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 138. Sigma-Tau Group Liposomes Drug Delivery Product
Table 139. Sigma-Tau Group Recent Development
Table 140. Ipsen (Onivyde) Corporation Information
Table 141. Ipsen (Onivyde) Description and Business Overview
Table 142. Ipsen (Onivyde) Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 143. Ipsen (Onivyde) Liposomes Drug Delivery Product
Table 144. Ipsen (Onivyde) Recent Development
Table 145. CSPC Corporation Information
Table 146. CSPC Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 147. CSPC Description and Business Overview
Table 148. CSPC Liposomes Drug Delivery Product
Table 149. CSPC Recent Development
Table 150. Teva Pharmaceutical Corporation Information
Table 151. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 152. Teva Pharmaceutical Description and Business Overview
Table 153. Teva Pharmaceutical Liposomes Drug Delivery Product
Table 154. Teva Pharmaceutical Recent Development
Table 155. Novartis Corporation Information
Table 156. Novartis Description and Business Overview
Table 157. Novartis Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 158. Novartis Liposomes Drug Delivery Product
Table 159. Novartis Recent Development
Table 160. Fudan-Zhangjiang Corporation Information
Table 161. Fudan-Zhangjiang Description and Business Overview
Table 162. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 163. Fudan-Zhangjiang Liposomes Drug Delivery Product
Table 164. Fudan-Zhangjiang Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Liposomes Drug Delivery Distributors List
Table 168. Liposomes Drug Delivery Customers List
Table 169. Liposomes Drug Delivery Market Trends
Table 170. Liposomes Drug Delivery Market Drivers
Table 171. Liposomes Drug Delivery Market Challenges
Table 172. Liposomes Drug Delivery Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomes Drug Delivery Product Picture
Figure 2. Global Liposomes Drug Delivery Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liposomes Drug Delivery Sales Market Share by Application in 2021 & 2027
Figure 6. Fungal Infection Therapy Examples
Figure 7. Cancer & Tumor Therapy Examples
Figure 8. Others Examples
Figure 9. Global Liposomes Drug Delivery Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Liposomes Drug Delivery Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Liposomes Drug Delivery Sales (K Vial) Growth Rate (2016-2027)
Figure 12. Global Liposomes Drug Delivery Price Trends Growth Rate (2016-2027) (USD/Vial)
Figure 13. Global Liposomes Drug Delivery Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Liposomes Drug Delivery Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Liposomes Drug Delivery Sales (K Vial) Growth Rate (2016-2027)
Figure 17. Europe Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Liposomes Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Liposomes Drug Delivery Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Liposomes Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Liposomes Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Liposomes Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Liposomes Drug Delivery Players Market Share by Revenue in Liposomes Drug Delivery: 2016 & 2020
Figure 28. Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Liposomes Drug Delivery Revenue Share by Type (2016-2021)
Figure 30. Global Liposomes Drug Delivery Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Liposomes Drug Delivery Revenue Share by Application (2016-2021)
Figure 32. Global Liposomes Drug Delivery Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 34. North America Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 35. Europe Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 36. Europe Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 37. China Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 38. China Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 39. Japan Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 40. Japan Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 41. Southeast Asia Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 42. Southeast Asia Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 43. India Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 44. India Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Liposomes Drug Delivery
Figure 47. Manufacturing Process Analysis of Liposomes Drug Delivery
Figure 48. Liposomes Drug Delivery Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs